Formulation & Delivery 2025

May 2025 | Basel, Switzerland

Connect with leading experts to explore strategic advances in formulation, drug delivery and RNA.

Event Page - Hero Banner 6
Overview Formulation & Drug Delivery Inhalation & Respiratory Drug Delivery RNA Therapeutics & Delivery

Dive Into Formulation & Delivery 2025: Explore Innovations in Formulation, Drug Delivery & RNA. 

Join 400+ leaders, experts and researchers at Formulation & Delivery 2025, connecting pharmaceutical & biotech representatives as well as academia for high-level discussions on the latest innovations in pharmaceutical drugs formulation, drug delivery & RNA development.

Formulation & Delivery 2025 features our ever-popular 11th Annual Formulation & Delivery Congress and 3rd Annual RNA Therapeutics & Delivery Congress and is attended by over 400 senior level experts in London to network, debate and discuss the industry’s pressing challenges & opportunities; fostering partnerships & collaborations in this field. Do not miss out on attending this event to stay at the forefront of the research – from innovation in small & large molecule drugs formulation, through to novel drug delivery systems and advances in RNA chemistry & therapeutics development.

11th Annual Formulation & Drug Delivery Congress

Join market-leading drug development professionals for high-level discussions on the latest innovations in formulation science and drug delivery. This must attend event will discuss the current state of the industry, looking at new strategies for enhancing biopharmaceutical formulations with AI as well as highlighting key updates in oral delivery of biologics and patient-centric approaches. Featuring a track on drug stability, characterization, and developability, the congress emphasizes advances in protein aggregation preventions and optimization of lyophilization strategies. 

Leading expert scientists working across formulation, drug delivery, bioanalysis, developability, and manufacturing science & technologies, representing global pharmaceutical organisations, leading biotechnology companies and internationally renowned academic institutions. 

Over 50 technical presentations and case studies focused on the critical topics in AI for automated formulations, enhanced drug delivery through vaccines, PROTAC, and exosomes, as well as an exploration of sustainable drug development.

Agenda at a Glance

  • Day One | Track 1: Small Molecule Formulation
  • Day One | Track 2: Large Molecule Delivery
  • Day One | Track 3: Preformulation Studies
  • Day Two | Track 1: Large Molecule Formulation
  • Day Two | Track 2: Small Molecule Drug Delivery
  • Day Two | Track 3: Process Chemistry & Pharmaceutical Materials Analysis

10th Annual Inhalation & Respiratory Drug Delivery Congress

Explore the forefront of inhaled therapies and delve into the novel formulations and delivery methods revolutionising respiratory treatments. Two comprehensive tracks will spotlight industry developments, covering inhaled biologics, particle engineering breakthroughs, diverse therapeutic case studies, and novel device development approaches. Participate in workshops, panels, and roundtable discussions to pioneer advancements in the field and stay at the forefront of innovation. 

Leading experts in inhalation, respiratory and nasal drug development & delivery science representing global pharmaceutical organisations, leading biotechnology companies and internationally renowned academic and research organisations.

Over 15 presentations and case studies focusing on the emerging therapies and key issues in inhalation and respiratory drug development as well as the latest developments in inhalation devices and digital & connected health.

Agenda at a Glance

Day One | Track 4: Formulation Development For Inhaled Therapies

Day Two | Track 3: Application Areas of Inhaled Therapies, Delivery & Device Development

3rd Annual RNA Therapeutics & Delivery Congress

Gain insights into the latest development, formulation and delivery of RNA therapeutics. Learn from key opinion leaders working to deliver RNA therapies for several therapeutic areas including infectious disease and cardiovascular disease. Across two in-depth sessions the latest improvements pushing the industry forward will be addressed: from mRNA characterisation, RNA delivery agents and viral vectors through to novel RNA drug discovery tools and RNAs as drug targets. Stay at the forefront of the growing interest in technologies including mRNA vaccines, siRNA as well as antisense and RNA interference.

Discuss the latest innovations in RNA chemistry & formulation strategies. Presentations will delve into developing new strategies to design these therapeutics, as well as scale up & manufacturing considerations and exploring the latest developments in delivery therapies outside the liver  

Discover collaborative solutions to RNA delivery strategies. Delve into viral vector and non-viral techniques as well as new approaches which target outside the liver 

Take a deep dive into RNA therapeutics case studies & commercialization strategies: from some of the leading RNA therapeutic companies including Sixfold Bioscience, Altamira Therapeutics, TransCode Therapeutics  

Agenda at a Glance

Day One | Track 1: RNA Formulation Strategies, Design & Development

Day Two | Track 1: RNA Drug Delivery

What to Expect


leading pharma, biotech, & academic delegates

hours of presentations, discussions & interactive content
hours of networking breaks, including speed networking & refreshments
hours of pre-arranged 1-2-1 meetings, facilitating business growth
Interactive Presentations
Exhibition Hall
Networking Drinks
Poster Display
Event App Swapcard

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

  • Engaging Thought Leadership

    Over 75 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
  • Global Technological Showcase

    An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
  • Networking Emphasis

    Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
  • Innovative Poster Displays

    Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions

Companies Represented Include

Meet Our Expert Speakers

The event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data, and industry outlooks. Below were some of the featured speakers at Formulation & Delivery 2024: 25 - 26 April 2024, London, UK

Declan Lowney
Director of Stability Sciences,
Janssen R&D
Kajsa Rådevik
Associate Director CMC Regulatory Affairs,
Naila El Kechai
Head of Biologics Formulation,
Paul Marshall
Regulatory Affairs Director,
Jazz Pharmaceuticals
Sam Nash
Associate Principal Scientist,
Amal Ali Elkordy
University of sunderland
Andrew Feilden
Director Analytical Science,
Bicycle TX
Annette Vinther Heydenreich
Principal Scientist,
Ben Forbes
Professor of Pharmaceutics,
King's College London
Cees Van Rijn
University of Amsterdam
Charley Wu
Professor of Chemical Engineering,
University of Surrey
Chris Broomell
Head of Analytical Development,
Omega Therapeutics
Chris Cardon
Founder Ziphius Vaccines,
Ziphius Vaccines
Christopher Locher
Chief Executive Officer,
Versatope Therapeutics
Covadonga Paneda
Chief Operating Officer,
Dan Bach Kristensen
Scientific Director,
Daniel Tondera
Head of Biology,
Pantherna Therapeutics GmbH
David Workman
Associate Principal Scientist,
Elena Sanna
Associate Principal Scientist,
Sixfold Bioscience
Elizabeth Ogden
Process Engineer,
Estelle Beguin
Director Technology Research,
Ethris GmbH
Florian Rosenthal
Senior Scientist,
F. Hoffman - La Roche Ltd.
Hyunhong James Min
Senior Scientist,
University of Oxford
Ijeoma Uchegbu
Professor of Pharmaceutical Nanoscience,
University College London
Ildikó Terebesi
Managing Director,
Janis Shute
Scientific Director,
University of Portsmouth
Jens Twellmeyer
Associate Director Science & Technology,
Jérôme Mantanus
Head of Materials Science,
UCB Pharma
Jonathan Reid
Professor of Physical Chemistry and Director of the EPSRC,
University of Bristol
Juha Monkare
Sr. Scientist,
Kamalinder K Singh
Professor of Pharmaceutical Technology and Drug Delivery,
University of Central Lancshire
Koen Raemdonck
Ghent University
Mahnoush Bahjat
Associate Director,
Martinus Capelle
Scientific Director,
Johnson & Johnson
Maurits Kleijnen
Head of Research,
Intract Pharma
Meike Harms
Lead Scientist,
Merck Healthcare KGaA
Nagy Habib
Lead Clinician and Head of the Department,
Imperial College London
Nathalie Wauthoz
Universite Libre de Bruxelles
Per-Olof Wahlund
Novo Nordisk A/S
Philip Rye
Chief Scientific Officer,
AlgiPharma AS
Richard Storey
Principal Scientist,
Rikke Dueholm
Senior Scientist,
Shayoni Dutta
Principal Data Scientist,
Simone Vecchi
Cmc leader,
Sophie Janbon
Stephen Pham
Senior Vice President,
Avalyn Pharma Inc.
Sune Andersen
Associate Director,
Janssen Pharmaceuticals
Supriyadi Hafiz
Senior Scientist,
Merck Life Science KGaA
Tjasa Vrlinic
Venkatesh Teja Banala
Biopharmaceutics Investigator,
Vincent Ling
Senior Director,
Takeda Pharmaceuticals
Yngve Mikkelsen
Chief Marketing Officer,
Yogeshwar Bachhav
AiCuris Anti-infective Cures AG

Interested in Sponsoring?

Oxford Global’s range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.

Learn more

Latest Resources

Enhancing Drug Stability & Exploring Novel Formulation Strategies

A Concise Report Featuring Insights From The Prominent Thought Leaders Of Formulation & Delivery UK 2024

Innovative Foam Technology Enhances Gene Therapy Delivery

Researchers at the Fred Hutch Cancer Center conducted a study investigating the potential of medicated foam as a gene therapy delivery vector. Their studies showed that a foam-based delivery system enhances the efficiency and safety of gene therapy by ensuring concentrated, controlled release of therapeutic agents.

Freeze-Drying 2.0: Examining the Potential of Thin Film Freezing

TFF Pharmaceuticals and the Cleveland Clinic team up to advance multivalent influenza vaccine candidates into preclinical phases.

Investigating the Potential of Inhaled Biologics in Treating Idiopathic Pulmonary Fibrosis

Positive results from Aileron Therapeutics' ongoing Phase Ib clinical trial gives hope to patients diagnosed with idiopathic pulmonary fibrosis (IPF).

Advanced Instruments: OsmoTECH® HT

Novel Nanorobots Pave the Way for Cancer Treatment

A preclinical study conducted by a team of scientists at the Institute for Bioengineering of Catalonia highlights the therapeutic potential of nanorobots in bladder cancer treatment.

Plan Your Visit

Full details regarding accommodation, travel directions, health and safety, and other logistical information for the event will be added here in the coming months.

Register Your Interest

Submit your details and a member of our team will be in touch